Author: Norman Peter
Publisher: Informa Healthcare
ISSN: 1354-3776
Source: Expert Opinion on Therapeutic Patents, Vol.19, Iss.11, 2009-11, pp. : 1629-1633
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
CCR1 Chemokine Receptor Antagonist
Current Pharmaceutical Design, Vol. 9, Iss. 15, 2003-06 ,pp. :
Species selectivity of a small molecule antagonist for the CCR1 chemokine receptor
By Liang M. Rosser M. Ng H.P. May K. Bauman J.G. Islam I. Ghannam A. Kretschmer P.J. Pu H. Dunning L. Snider R.M. Morrissey M.M. Hesselgesser J. Perez H.D. Horuk R.
European Journal of Pharmacology, Vol. 389, Iss. 1, 2000-02 ,pp. :
Expert Opinion on Therapeutic Patents, Vol. 20, Iss. 11, 2010-11 ,pp. :
A dual CCR2/CCR5 chemokine antagonist, BMS-813160?
By Norman Peter
Expert Opinion on Therapeutic Patents, Vol. 21, Iss. 12, 2011-12 ,pp. :